Cargando…
Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review
To review the success rate and efficiency of industry-sponsored phase 2/3 clinical trials for adjunctive therapies for antidepressant partial- and non-responders with major depressive disorder (MDD), a systematic search of Pubmed/Medline was conducted, in addition to abstracts of major psychiatric m...
Autores principales: | Salloum, Naji C., Fava, Maurizio, Ball, Sophia, Papakostas, George I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473846/ https://www.ncbi.nlm.nih.gov/pubmed/31988433 http://dx.doi.org/10.1038/s41380-020-0646-3 |
Ejemplares similares
-
A survey of five antidepressant properties influencing clinician’s treatment choices in MDD
por: Papakostas, George I, et al.
Publicado: (2007) -
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
por: Papakostas, George I., et al.
Publicado: (2008) -
Why is Diagnosing MDD Challenging?
Publicado: (2016) -
POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDD
por: Prenoveau, Jason, et al.
Publicado: (2013) -
From MDD concepts to experiments and illustrations
por: Babau, Jean-Philippe, et al.
Publicado: (2006)